TrialLancet (London, England)2016

Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study.

James C Yao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.